Lineage Cell Therapeutics Inc.
OpRegenĀ® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity[...]
03/26/2024 | Press release | Distributed by Public on 03/26/2024 07:57
Please select the service you want to use:
Smartlinks | Erste Bank Hungary Zrt. | Erste Group Bank AG | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Financial Services | Banking | Securities Issuers | Private Companies | Banks | Corporate Debt Issuers
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact